Studies found that women suffered more pain with the abortion pill

A report on the abortion pill concluded:

“More pain was reported with medical abortion both during the abortion and during the follow up period. (Jensen found 77.1% of medical abortion patients reported pain vs. 10.5% of surgical abortion patients.)”

It cited the following studies:

Jensen JT, Astley SJ, Morgan E, Nichols MD. Outcomes of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Contraception 1999;59:153-9

Winikoff B, Sivin I, Coyaji KJ, et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone and misoprostol versus surgical abortion. Am J Obstet Gynecol 1997;176:431-7.

Cabezas E. Medical versus surgical abortion. Internat J Gynaecol & Obstet. 1998;63 Supp. 1, S141-6.

Elul B, Ellertson C, Winikoff B, Coyaji K. Side effects of mifepristone-misoprostol abortion versus surgical abortion. Data from a trial in China, Cuba, and India. Contraception 1999;59(2):107-14

“The FDA and RU-486: lowering the standard for women’s health.” Staff report prepared for the Hon. Mark Souder, Chariman, Subcommitte on Criminal Justice, Drug Policy and Human Resouces, October 2006

Source:

Medical Officer’s Review of Amendments 024 and 033, Final Reports for the U.S. Clinical Trials Inducing Abortion up to 63 Days Gestational Age and Complete Responses Regarding Distribution System and Phase 4 Commitments, Finalized November 22, 1999 (dated January 27, 2000)

Share on Facebook

Owner of second pill in the abortion pill regimen opposed its use in abortion

Cytotec is another name for the drug misoprostol, which was originally developed to treat ulcers but is now used with the abortion pill, mifepristone, to cause abortions. Misoprostol causes the uterus to contract, causing a woman to expel her baby. Mifepristone kills the baby by separating the placenta and cutting off the child’s oxygen and nutrition supply.

The company that has the patent to misoprostol/Cytotec opposed its use in abortions. According to author Melissa Haussman:

“The owner of the Cytotec patent, the Searle Company, consistently lobbied against having its drug included in an official medical abortion procedure.… In August 2000, one month after the drug had gone off-patent, Searle sent a letter to medical practitioners to warn them that Cytotec was not FDA approved for labor or abortion induction, although practitioners already knew that. It has strongly been suggested that the timing of that action was linked to avoiding future liability. Until misoprostol went off patent in July 2000, Searle acted to push any potential US manufacturer away from making mifepristone, since misoprostol would be required as an accompaniment.”

Melissa Haussman Reproductive Rights and the State: Getting the Birth Control, RU-486, and Morning-After Pills and the Gardasil Vaccine to the US Market (Santa Barbara, California: Praeger, 2013) 99

So Searle felt that it was unsafe to use misoprostol to induce abortions or labor, and was afraid of lawsuits due to this.

However, Searle lost the battle to control the use of their drug.

Share on Facebook

Women who want to be unaware of when the baby dies would be bothered by abortion pill

An article in National Right to Life News quotes two women who had abortion by pill saying that other women may not want to go through their experience:

“According to the New York Times, two RU-486 [abortion pill] patients selected by the Population Council to appear at its October 27, 1994, press conference “agreed that some women who wanted to remain unaware of when the embryo was flushed out of the body would not like the procedure.”

Randall K O’Bannon “RU-486” National Right to Life News Jan 1995

Share on Facebook

Abortionist: Doctors who give RU-486 should have surgical access

From an interview with an abortion provider:

Interviewer: The most recent controversy to the abortion rights activists is that the FDA is now talking about limiting RU-486’s access when it does become available, by requiring special licensing of those dispensing the pill and that they be within a certain distance of a hospital. Do you think these proposed hurdles are justified?

Ab: yes, to some extent. If a patient begins to bleed heavily during a medical abortion, the patient might need surgical intervention. The uterus needs to be evacuated so we can clamp down and stop the bleeding. If everyone out there is prescribing RU-486 to people who do not have surgical access, then there’s bound to be some kind of a problem.”

David Morton, “Anonymous Abortion Provider” July 12-July 18. 2000 Alternative Weekly

Pro-Choice activists are adamantly opposed to regulating RU-486 and requiring doctors and clinics who dispense it to have surgical facilities available.

Share on Facebook

Dr. Randall K. O’Bannon on RU-486

Dr. Randall K. O’Bannon, who has tracked chemical abortifacients such as RU486 (mifepristone) for National Right to Life for a number of years, discusses the dangers of RU-486 in an article about a proposed law that would regulate facilities that offer it:

“It isn’t as simple as having a doctor pass out some pills. Women undergoing these chemical abortions will endure heavy bleeding, painful cramping, and various forms of gastro-intestinal distress, even if these are ‘successful.'”

Some women “hemorrhage and need emergency surgery,” O’Bannon noted. “A number of women have died in the U.S. after contracting deadly infections. The last thing you want is a doctor who is unprepared to deal with these outcomes.”

Missouri Abortion Clinic Law Enjoined National Right to Life News September 1, 2007

 

Share on Facebook

Dr. Susan Poppema on RU-486

Dr. Susan Poppema, NAF president, discusses one problem with RU-486.

“Having a group of women doing a lot of bleeding and cramping in your office, when they would rather be home, doesn’t do much for the [patient] flow in your clinic.”

She argues that women should be sent home to abort alone – despite the risk to a woman’s health and the lack of medical attention should something go wrong. This is because she is concerned about  “patient flow” efficiency in her clinic.

Wendy Wright “The Deceit behind RU-486: Who’s Really in Control?” Family Voice, November/December 2000

Share on Facebook